Evidence map›Paper›PMID 37741820›Full record

ArticleScientific reports2023

Improved accuracy in colorectal cancer tissue decomposition through refinement of established deep learning solutions.

Fabi Prezja, Sami Äyrämö, Ilkka Pölönen, Timo Ojala, Suvi Lahtinen, Pekka Ruusuvuori, Teijo Kuopio

Abstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Fabi PrezjaFaculty of Information Technology, University of Jyväskylä, Jyväskylä, 40014, Finland. faprezja@jyu.fi.
Sami ÄyrämöFaculty of Information Technology, University of Jyväskylä, Jyväskylä, 40014, Finland.
Ilkka PölönenFaculty of Information Technology, University of Jyväskylä, Jyväskylä, 40014, Finland.
Timo OjalaFaculty of Information Technology, University of Jyväskylä, Jyväskylä, 40014, Finland.
Suvi LahtinenFaculty of Information Technology, University of Jyväskylä, Jyväskylä, 40014, Finland.
Pekka RuusuvuoriInstitute of Biomedicine, Cancer Research Unit, University of Turku, Turku, 20014, Finland.
Teijo KuopioDepartment of Education and Research, Hospital Nova of Central Finland, Jyväskylä, 40620, Finland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hematoxylin and eosin-stained biopsy slides are regularly available for colorectal cancer patients. These slides are often not used to define objective biomarkers for patient stratification and treatment selection. Standard biomarkers often pertain to costly and slow genetic tests. However, recent work has shown that relevant biomarkers can be extracted from these images using convolutional neural networks (CNNs). The CNN-based biomarkers predicted colorectal cancer patient outcomes comparably to gold standards. Extracting CNN-biomarkers is fast, automatic, and of minimal cost. CNN-based biomarkers rely on the ability of CNNs to recognize distinct tissue types from microscope whole slide images. The quality of these biomarkers (coined 'Deep Stroma') depends on the accuracy of CNNs in decomposing all relevant tissue classes. Improving tissue decomposition accuracy is essential for improving the prognostic potential of CNN-biomarkers. In this study, we implemented a novel training strategy to refine an established CNN model, which then surpassed all previous solutions . We obtained a 95.6% average accuracy in the external test set and 99.5% in the internal test set. Our approach reduced errors in biomarker-relevant classes, such as Lymphocytes, and was the first to include interpretability methods. These methods were used to better apprehend our model's limitations and capabilities.

Indexed as

Colorectal NeoplasmsDeep LearningBiopsyEosine Yellowish-(YS)Genetic TestingHumansEosine Yellowish-(YS)

Identifiers

PMID37741820
PMCPMC10517936

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.